ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 655905 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 655905; 2) Community: the network communities that were significantly associated with the response to NSC 655905; 3) Molecule: the relationships between components within communities and NSC 655905; 4) MDR: the compounds that were significantly associated with the NSC 655905.

NSC Compound Enrichment Correlation
NSC 695943 6H-[1,2,3]triazolo[4,5,1-de]acridin-6-one, 5,5'-[(1,2-ethanediyl)bis(imino)bis (3,1-propanediyl)bis(imino)]bis-, dimethanesulfonate 0.024108502230778 -0.1900198
NSC 704886 2-Butenedioic acid, 2-[5-chloro-2,4-dioxo-3-(2-propynyl)-1H,3H-pyrimidinyl]-,diethyl ester, (2E)- 0.024108502230778 -0.10836789
NSC 706486 Null 0.024108502230778 0.32274724
NSC 711806 Null 0.024108502230778 -0.1357085
NSC 732844 1-[4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-2-fluorobenzene 0.024108502230778 0.31431615
NSC 100071 component of Halotex 0.0241085022307781 -0.11745175
NSC 143925 Pekilocerin A 0.0241085022307781 -0.13661554
NSC 401268 Bergaptenquinone 0.0241085022307781 0.24889629
NSC 634037 4-amino-3-bromo-1-(.beta.-D-ribofuranosyl)pyrrolo[2,3-d] pyridazine 0.0241085022307781 0.030941441
NSC 644916 ANTINEOPLASTIC-644916 0.0241085022307781 0.0090636187
Total:45  Current:18    [First] [Prev] [Next] [Last]